Contact Info
Newborn Screening Program
651-201-5466
800-664-7772 (toll-free)
Newborn Screening Panel and Timeline
Minnesota's Newborn Screening Panel
Disorder coming soon:
The following new condition has been approved for addition to Minnesota's newborn screening panel.
- Mucopolysaccharidosis Type II (MPS II)
- Metachromatic Leukodystrophy (MLD)
Implementation is currently in progress and screening has not yet begun.
The newborn screening panel refers to the list of disorders that newborns are screened for shortly after birth. In Minnesota, disorders are added to this panel by the Commissioner of Health with advice and recommendations from Minnesota's Advisory Committee on Heritable and Congenital Disorders.
Screening panels may vary from state to state. The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) provides national recommendations on which disorders should be screened for in all states to the Secretary of Health and Human Services. However, each state ultimately determines which disorders to include in its panel.
Newborn Screening Disorder Panel (PDF)
Minnesota's Newborn Screening Timeline
| Primary targets of newborn screening | Year/date screening started |
|---|---|
| Phenylketonuria | 1964 |
| Congenital hypothyroidism | 1968 |
| Galactosemia | 1974 |
| Sickle cell disease | 1988 |
| Sickle-C disease | 1988 |
| S-βeta thalassemia | 1988 |
| Congenital adrenal hyperplasia | 8/13/1992 |
| 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency | 1/18/2001 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | 1/18/2001 |
| Argininosuccinate acidemia | 1/18/2001 |
| Beta ketothiolase deficiency | 1/18/2001 |
| Carnitine uptake defect | 1/18/2001 |
| Citrullinemia type 1 | 1/18/2001 |
| Glutaric acidemia type 1 | 1/18/2001 |
| Homocystinuria | 1/18/2001 |
| Isovaleric acidemia | 1/18/2001 |
| Long-chain hydroxyacyl-CoA dehydrogenase deficiency | 1/18/2001 |
| Maple syrup urine disease | 1/18/2001 |
| Medium-chain acyl-CoA dehydrogenase deficiency | 1/18/2001 |
| Methylmalonic acidemia (3 types) | 1/18/2001 |
| Multiple CoA carboxylase deficiency | 1/18/2001 |
| Propionic acidemia | 1/18/2001 |
| Trifunctional protein deficiency | 1/18/2001 |
| Tyrosinemia type 1 | 1/18/2001 |
| Very long-chain acyl-CoA dehydrogenase deficiency | 1/18/2001 |
| Biotinidase deficiency | 10/26/2004 |
| Cystic fibrosis | 3/1/2006 |
| Hearing loss | 5/26/2007 (date screening was mandated) |
| Severe combined immunodeficiency | 1/7/2013 |
| Critical congenital heart disease | 8/1/2013 (date screening was mandated) |
| X-linked adrenoleukodystrophy | 2/6/2017 |
| Mucopolysaccharidosis type I | 8/1/2017 |
| Pompe disease | 8/1/2017 |
| Spinal muscular atrophy | 3/1/2018 |
| Congenital cytomegalovirus (cCMV) | 2/6/2023 |
| Krabbe Disease | 2/26/2024 |
| Duchenne muscular dystrophy | 2/24/2025 |
| Guanidinoacetate methyltransferase (GAMT) deficiency | 2/24/2025 |
Last Updated: 05/09/2025